Mechanism of Inhibition of β-Site Amyloid Precursor Protein-cleaving Enzyme (BACE) by a Statine-based Peptide
Open Access
- 1 June 2001
- journal article
- Published by Elsevier
- Vol. 276 (26) , 23790-23794
- https://doi.org/10.1074/jbc.m101896200
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Proteolytic Activation of Recombinant Pro-memapsin 2 (Pro-β-secretase) Studied with New Fluorogenic SubstratesBiochemistry, 2000
- Expression Analysis of BACE2 in Brain and Peripheral TissuesJournal of Biological Chemistry, 2000
- Design of Potent Inhibitors for Human Brain Memapsin 2 (β-Secretase)Journal of the American Chemical Society, 2000
- Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor proteinProceedings of the National Academy of Sciences, 2000
- Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activityNature, 1999
- Purification and cloning of amyloid precursor protein β-secretase from human brainNature, 1999
- β-Secretase Cleavage of Alzheimer's Amyloid Precursor Protein by the Transmembrane Aspartic Protease BACEScience, 1999
- Alzheimer's Disease and the Amyloid β ProteinJournal of Neurochemistry, 1999
- Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activityNature, 1999
- Binding of a reduced peptide inhibitor to the aspartic proteinase from Rhizopus chinensis: implications for a mechanism of action.Proceedings of the National Academy of Sciences, 1987